The DOI matches its Crossref record; 153 of the 156 references it cites were found in a registry or an index.
Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies
Open accessAbstract
BACKGROUND: Incomplete adherence to tuberculosis (TB) treatment increases the risk of delayed culture conversion with continued transmission in the community, as well as treatment failure, relapse, and development or amplification of drug resistance. We conducted a systematic review and meta-analysis of adherence interventions, including directly observed therapy (DOT), to determine which approaches lead to improved TB treatment outcomes. METHODS AND FINDINGS: We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB through February 3, 2018. We included randomized controlled trials (RCTs) as well as prospective and retrospective cohort studies (CSs) with an internal or external control group that evaluated any adherence intervention and conducted a meta-analysis of their impact on TB treatment outcomes. Our search identified 7,729 articles, of which 129 met the inclusion criteria for quantitative analysis. Seven adherence categories were identified, including DOT offered by different providers and at various locations, reminders and tracers, incentives and enablers, patient education, digital technologies (short message services [SMSs] via mobile phones and video-observed therapy [VOT]), staff education, and combinations of these interventions. When compared with DOT alone, self-administered therapy (SAT) was associated with lower rates of treatment success (CS: risk ratio [RR] 0.81, 95% CI 0.73-0.89; RCT: RR 0.94, 95% CI 0.89-0.98), adherence (CS: RR 0.83, 95% CI 0.75-0.93), and sputum smear conversion (RCT: RR 0.92, 95% CI 0.87-0.98) as well as higher rates of development of drug resistance (CS: RR 4.19, 95% CI 2.34-7.49). When compared to DOT provided by healthcare providers, DOT provided by family members was associated with a lower rate of adherence (CS: RR 0.86, 95% CI 0.79-0.94). DOT delivery in the community versus at the clinic was associated with a higher rate of treatment success (CS: RR 1.08, 95% CI 1.01-1.15) and sputum conversion at the end of two months (CS: RR 1.05, 95% CI 1.02-1.08) as well as lower rates of treatment failure (CS: RR 0.56, 95% CI 0.33-0.95) and loss to follow-up (CS: RR 0.63, 95% CI 0.40-0.98). Medication monitors improved adherence and treatment success and VOT was comparable with DOT. SMS reminders led to a higher treatment completion rate in one RCT and were associated with higher rates of cure and sputum conversion when used in combination with medication monitors. TB treatment outcomes improved when patient education, healthcare provider education, incentives and enablers, psychological interventions, reminders and tracers, or mobile digital technologies were employed. Our findings are limited by the heterogeneity of the included studies and lack of standardized research methodology on adherence interventions. CONCLUSION: TB treatment outcomes are improved with the use of adherence interventions, such as patient education and counseling, incentives and enablers, psychological interventions, reminders and tracers, and digital health technologies. Trained healthcare providers as well as community delivery provides patient-centered DOT options that both enhance adherence and improve treatment outcomes as compared to unsupervised, SAT alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



























Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The consequences of poor adherence include delayed sputum culture conversion, treatment failure, relapse, prolonged infectiousness, development of drug resistance, and increased morbidity and mortality [4,5].”
From Psychosocial Interventions for Improving Treatment Adherence in Tuberculosis Patients: A Scoping Review of Evidence-Based Approaches. (2026) · cites this paper as [4]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Previous research has indicated that treatment adherence interventions (eg, patient counselling and education, reminders, and digital health technologies)47, 48 and social protection interventions (eg, cash transfers and economic incentives)49, 50 can increase treatment adherence and prevent mortality.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
(2014) · Medical Entomology and Zoology · Cited by 17,633
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17670-8 · Cited by 2,544
Free, C., Phillips, G., Galli, L., Watson, L., Felix, L., Edwards, P., Patel, V., & Haines, A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001362 · Cited by 1,766 · cited 1×
“Psychological interventions aim to support via psychological or emotional counseling or a social network of peers undergoing TB treatment as a means of improving adherence to TB treatment [18,19].”
BackgroundNahid, P., Dorman, S. E., Alipanah, N., Barry, P. M., Brozek, J. L., Cattamanchi, A., Chaisson, L. H., Chaisson, R. E., Daley, C. L., Grzemska, M., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw376 · Cited by 1,170
Self-citationPatient Adherence to Tuberculosis Treatment: A Systematic Review of Qualitative Research
Munro, S. A., Lewin, S. A., Smith, H. J., Engel, M. E., Fretheim, A., & Volmink, J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040238 · Cited by 1,080
Assessing the Gold Standard — Lessons from the History of RCTs
Bothwell, L. E., Greene, J. A., Podolsky, S. H., & Jones, D. S. (2016) · New England Journal of Medicine · doi:10.1056/nejmms1604593 · Cited by 664
Directly observed therapy for treating tuberculosis
Karumbi, J., & Garner, P. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003343.pub4 · Cited by 644
The Effect of Directly Observed Therapy on the Rates of Drug Resistance and Relapse in Tuberculosis
Weis, S. E., Slocum, P. C., Blais, F. X., King, B., Nunn, M., Matney, G. B., Gomez, E., & Foresman, B. H. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404283301702 · Cited by 589 · cited 2×
“Only three CSs compared the impact of DOT on the development of drug resistance compared with SAT, one of which found no significant difference [4,59,70].”
BackgroundResultOrenstein, E. W., Basu, S., Shah, N. S., Andrews, J. R., Friedland, G. H., Moll, A. P., Gandhi, N. R., & Galvani, A. P. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70041-6 · Cited by 540
Mitchison, D. A. (1998) · PubMed · Cited by 288
Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis
Zwarenstein, M., Schoeman, J. H., Vundule, C., Lombard, C. J., & Tatley, M. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04022-7 · Cited by 281
Directly observed therapy for tuberculosis: history of an idea
Bayer, R., Wilkinson, D., & Bayer, R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91090-5 · Cited by 254 · cited 1×
“One of the most commonly used adherence interventions is directly observed therapy (DOT), in which a health worker, family member, or community member observes the patient taking TB medications [12].”
BackgroundLiu, X., Lewis, J. J., Zhang, H., Lu, W., Zhang, S., Zheng, G., Bai, L., Li, J., Li, X., Chen, H., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001876 · Cited by 234
Walley, J. D., Khan, M. A., Newell, J. N., & Khan, M. H. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04129-5 · Cited by 230
A Patient Education Program to Improve Adherence Rates with Antituberculosis Drug Regimens
Morisky, D. E., Malotte, C. K., Choi, P., Davidson, P., Rigler, S., Sugland, B., & Langer, M. (1990) · Health Education Quarterly · doi:10.1177/109019819001700303 · Cited by 224
Tola, H. H., Shojaeizadeh, D., Tol, A., Garmaroudi, G., Yekaninejad, M. S., Kebede, A., Ejeta, L. T., Kassa, D., & Klinkenberg, E. (2016) · PLOS ONE · doi:10.1371/journal.pone.0155147 · Cited by 215
Yassin, M. A., Datiko, D. G., Tulloch, O., Markos, P., Aschalew, M., Shargie, E. B., Dangisso, M. H., Komatsu, R., Sahu, S., Blok, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063174 · Cited by 176
Thiam, S., LeFevre, A. M., Hane, F., Ndiaye, A., Ba, F., Fielding, K. L., Ndir, M., & Lienhardt, C. (2007) · JAMA · doi:10.1001/jama.297.4.380 · Cited by 175
Datiko, D. G., & Lindtjørn, B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005443 · Cited by 173
Xu, W., Lu, W., Zhou, Y., Zhu, L., Shen, H., & Wang, J. (2009) · BMC Health Services Research · doi:10.1186/1472-6963-9-169 · Cited by 163
Bashar, M., Alcabes, P., Rom, W. N., & Condos, R. (2001) · Chest · doi:10.1378/chest.120.5.1514 · Cited by 163
Newell, J. N., Baral, S., Pande, S. B., Bam, D. S., & Malla, P. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68380-3 · Cited by 149
Tuberculosis, poverty, and "compliance": lessons from rural Haiti.
Farmer, P. E., Robin, S., Ramilus, S. L., & Kim, J. Y. (1991) · PubMed · Cited by 147
Wright, J., Walley, J. D., Philip, A. Z., Pushpananthan, S., Dlamini, E., Newell, J. N., & Dlamini, S. (2004) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2004.01230.x · Cited by 147
Community tuberculosis care through “TB clubs” in rural North Ethiopia
Demissie, M., Getahun, H., & Lindtjørn, B. (2003) · Social Science & Medicine · doi:10.1016/s0277-9536(02)00182-x · Cited by 140
Incentives and enablers to improve adherence in tuberculosis
Lutge, E. E., Wiysonge, C. S., Knight, S. E., Sinclair, D., & Volmink, J. A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007952.pub3 · Cited by 137 · cited 1×
“Other interventions aimed at supporting adherence through DOT include incentives, which are material or financial rewards provided to those adhering treatment [15], and enablers, which are interventions that allow patients to overcome economic constraints associated with DOT, such as absence from work or the direct an…”
BackgroundToczek, A., Cox, H. S., du Cros, P., Cooke, G., & Ford, N. P. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0537 · Cited by 133
Patient education and counselling for promoting adherence to treatment for tuberculosis
M’Imunya, J. M., Kredo, T., & Volmink, J. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006591.pub2 · Cited by 132 · cited 1×
“Other interventions focus on providing education on TB, its treatment, and prevention to help patients make informed decisions and the healthcare team to deliver patient-centered care [16].”
BackgroundKhan, M. A., Walley, J. D., Witter, S. N., Imran, A., & Safdar, N. (2002) · Health Policy and Planning · doi:10.1093/heapol/17.2.178 · Cited by 130
Mohammed, S., Glennerster, R., & Khan, A. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162944 · Cited by 125
Enhancing management of tuberculosis treatment with video directly observed therapy in New York City
Chuck, C., Robinson, E. W., Macaraig, M., Alexander, M., & Burzynski, J. N. (2016) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.15.0738 · Cited by 124
Kamolratanakul, P., Sawert, H., Lertmaharit, S., Kasetjaroen, Y., Akksilp, S., Tulaporn, C., Punnachest, K., Na-Songkhla, S., & Payanandana, V. (1999) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(99)90379-6 · Cited by 120
Pasipanodya, J. G., & Gumbo, T. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit167 · Cited by 119
Baral, S., Aryal, Y., Bhattrai, R., King, R., & Newell, J. N. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-46 · Cited by 109
Effect of pharmacist-led patient education on adherence to tuberculosis treatment
Clark, P. M., Karagöz, T., Apikoğlu-Rabuş, Ş., & İzzettin, F. V. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp050543 · Cited by 108
Torrens, A. W., Rasella, D., Boccia, D., Maciel, E. L. N., Nery, J. S., Olson, Z. D., Barreira, D., & Sanchez, M. N. (2016) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trw011 · Cited by 107
Abu, S. H., Medhin, G., Girma, B., Melese, M., Mekonen, A., Suarez, P. G., & Ameni, G. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-782 · Cited by 107
Martins, N., Morris, P. S., & Kelly, P. M. (2009) · BMJ · doi:10.1136/bmj.b4248 · Cited by 103
Tuberculosis Treatment Outcomes
Jasmer, R. M., Seaman, C. B., Jarlsberg, L. G., Kawamura, L. M., Osmond, D. H., & Daley, C. L. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-095oc · Cited by 103 · cited 3×
“Only three CSs compared the impact of DOT on the development of drug resistance compared with SAT, one of which found no significant difference [4,59,70].”
BackgroundResultSelf-citationLienhardt, C., & Ogden, J. (2004) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2004.01273.x · Cited by 94
Tuberculosis treatment adherence and fatality in Spain
the Working Group on Completion of Tuberculosis Treatment in Spain (Study ECUTTE), Caylà, J. A., Rodrigo, T., Manzano, J. R., Caminero, J. A., Vidal, R., García-García, J.-M., Blanquer, R., & Casals, M. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-121 · Cited by 94
Mobile health to improve tuberculosis care and control: a call worth making [Review article]
Denkinger, C. M., Grenier, J.-Y., Stratis, A. K., Akkihal, A., Pant-Pai, N., & Pai, M. (2013) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0638 · Cited by 93 · cited 1×
“Psychological interventions aim to support via psychological or emotional counseling or a social network of peers undergoing TB treatment as a means of improving adherence to TB treatment [18,19].”
BackgroundEffectiveness of supervised, intermittent therapy for tuberculosis in HIV-infected patients
Alwood, K., Keruly, J. C., Moore-Rice, K., Stanton, D. L., Chaulk, C. P., & Chaisson, R. E. (1994) · AIDS · doi:10.1097/00002030-199408000-00010 · Cited by 93
Balasubramanian, V., Oommen, K. O., & Samuel, R. (2000) · PubMed · Cited by 91
Liu, Q., Abba, K., Alejandria, M. M., Sinclair, D., Balanag, V. M., & Lansang, M. A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006594.pub3 · Cited by 90
Home Videophones Improve Direct Observation in Tuberculosis Treatment: A Mixed Methods Evaluation
Wade, V., Karnon, J. D., Eliott, J., & Hiller, J. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050155 · Cited by 90
Video directly observed therapy for treatment of tuberculosis is patient-oriented and cost-effective
Mirsaeidi, M. S., Farshidpour, M., Banks-Tripp, D., Hashmi, S., Kujoth, C., & Schraufnagel, D. E. (2015) · European Respiratory Journal · doi:10.1183/09031936.00011015 · Cited by 87 · cited 1×
“In recent years, video-observed therapy (VOT) has gained attention as an alternative way of delivering DOT [13,14].”
BackgroundCurrent status of treatment completion and fatality among tuberculosis patients in Spain.
Caylà, J. A., Caminero, J. A., Rey, R. D., Lara, N., Vallès, X., & Galdós-Tangüis, H. (2004) · PubMed · Cited by 85
Iribarren, S., Beck, S. L., Pearce, P. F. F., Chirico, C., Etchevarria, M., Cardinale, D., & Rubinstein, F. (2013) · Tuberculosis Research and Treatment · doi:10.1155/2013/349394 · Cited by 77
Lutge, E. E., Lewin, S. A., Volmink, J. A., Friedman, I., & Lombard, C. J. (2013) · Trials · doi:10.1186/1745-6215-14-154 · Cited by 68
Liefooghe, R., Suetens, C., Meulemans, H., Moran, M. B., & Muynck, A. D. (1999) · PubMed · Cited by 66
Sudarsanam, T. D., John, J. K., Kang, G., Mahendri, V., Gerrior, J., Franciosa, M., Gopal, S., John, K. R., Wanke, C. A., & Muliyil, J. (2011) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2011.02761.x · Cited by 66
Lewin, S. A., Dick, J., Zwarenstein, M., & Lombard, C. J. (2005) · Europe PMC (PubMed Central) · Cited by 64
Automated Telephone Reminders in Tuberculosis Care
Tanke, E. D., & Leirer, V. O. (1994) · Medical Care · doi:10.1097/00005650-199404000-00006 · Cited by 64
Does directly observed therapy (DOT) reduce drug resistant tuberculosis?
Moonan, P. K., Quitugua, T. N., Pogoda, J. M., Woo, G., Drewyer, G., Sahbazian, B., Dunbar, D. F., Jost, K. C., Jr., Wallace, C. E., & Weis, S. E. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-19 · Cited by 64 · cited 1×
“It must be noted that most of the literature on adherence interventions included in our meta-analysis did not evaluate the impact of adherence interventions on relapse and development of drug resistance, which are critical outcomes of interest for population-level TB management [2].”
BackgroundMacq, J., Solís, A., Martinez, G., & Martiny, P. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-154 · Cited by 63
Dick, J., & Lombard, C. J. (1997) · PubMed · Cited by 63
Wandwalo, E. R., Kapalata, N., Egwaga, S., & Mørkve, O. (2004) · PubMed · Cited by 63
Videophone utilization as an alternative to directly observed therapy for tuberculosis.
Krueger, K., Ruby, D., Cooley, P., Montoya, B., Exarchos, A., Djojonegoro, B. M., & Field, K. J. (2010) · PubMed · Cited by 62
Broomhead, S., & Mars, M. (2012) · Telemedicine and e-Health · doi:10.1089/tmj.2011.0143 · Cited by 61
Thomson, K. A., Cheti, E., & Reid, T. (2011) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2011.02.011 · Cited by 61
Text messaging to decrease tuberculosis treatment attrition in TB-HIV coinfection in Uganda
Hermans, S., Elbireer, S., Tibakabikoba, H., Hoefman, B., & Manabe, Y. C. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s135540 · Cited by 61
Zwarenstein, M., Schoeman, J., Vundule, C., Lombard, C. J., & Tatley, M. V. (2000) · PubMed · Cited by 61
Fang, X.-H., Guan, S., Tang, L., Tao, F., Zou, Z., Wang, J.-X., Kan, X.-H., Wang, Q.-Z., Zhang, Z., Cao, H., et al. (2017) · Medical Science Monitor · doi:10.12659/msm.904957 · Cited by 60
Tuberculosis treatment with mobile-phone medication reminders in northern Thailand.
Kunawararak, P., Pongpanich, S., Chantawong, S., Pokaew, P., Traisathit, P., Srithanaviboonchai, K., & Plipat, T. (2011) · PubMed · Cited by 59
Manders, A. J., Banerjee, A., van den Borne, H. W., Harries, A. D., Kok, G., & Salaniponi, F. M. L. (2001) · PubMed · Cited by 57
Lwilla, F., Schellenberg, D. M., Masanja, H., Acosta, C. J., Galindo, C. M., Aponte, J. J., Egwaga, S., Njako, B., Ascaso, C., Tanner, M., et al. (2003) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2003.00999.x · Cited by 56
Moalosi, G., Floyd, K., Phatshwane, J., Moeti, T. L., BINKIN, N. J., & Kenyon, T. A. (2003) · PubMed · Cited by 54
Jahnavi, G., & Sudha, C. H. (2010) · PubMed · Cited by 52
Randomized Clinical Trials and Observational Studies: Is There a Battle?
Chávez‐MacGregor, M., & Giordano, S. H. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.7487 · Cited by 52
Lei, X., Huang, K., Liu, Q., Jie, Y.-F., & Tang, S. (2016) · Infectious Diseases of Poverty · doi:10.1186/s40249-016-0134-9 · Cited by 51
Al‐Hajjaj, M. S., & Al-Khatim, I. M. (2000) · PubMed · Cited by 51
Psychotherapy Improves Compliance with Tuberculosis Treatment
Janmeja, A. K., Das, S. K., Bhargava, R., & Chavan, B. S. (2005) · Respiration · doi:10.1159/000086251 · Cited by 50
Sinkou, H., Hurevich, H., Rusovich, V., Zhylevich, L., Falzon, D., de Colombani, P., Dadu, A., Dara, M., Story, A., & Skrahina, A. M. (2017) · European Respiratory Journal · doi:10.1183/13993003.02049-2016 · Cited by 49 · cited 1×
“In recent years, video-observed therapy (VOT) has gained attention as an alternative way of delivering DOT [13,14].”
BackgroundSelf-citationDirectly Observed Therapy and Improved Tuberculosis Treatment Outcomes in Thailand
Anuwatnonthakate, A., Limsomboon, P., Nateniyom, S., Wattanaamornkiat, W., Komsakorn, S., Moolphate, S., Chiengsorn, N., Kaewsa-ard, S., Sombat, P., Siangphoe, U., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003089 · Cited by 48
Evaluation of community contribution to tuberculosis control in Cape Town, South Africa.
Dudley, L., Azevedo, V., Grant, R., Schoeman, J. H., Dikweni, L., & Maher, D. (2003) · PubMed · Cited by 48
A spoonful of sugar...: improving adherence to tuberculosis treatment using financial incentives.
BOCK, N. N., Sales, R. M., Rogers, T., & DeVoe, B. (2001) · PubMed · Cited by 48
Sripad, A., Castedo, J., Danford, N., Zaha, R., & Freile, C. (2014) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.13.0253 · Cited by 47
Inter-relations between relapses, drug regimens and compliance with treatment in tuberculosis
Ormerod, L. P., & Prescott, R. J. (1991) · Respiratory Medicine · doi:10.1016/s0954-6111(06)80087-9 · Cited by 46
Wei, X., Zou, G., Yin, J., Walley, J. D., Yang, H., Kliner, M., & Mei, J. (2012) · Infectious Diseases of Poverty · doi:10.1186/2049-9957-1-9 · Cited by 46
Shin, S., Livchits, V., Connery, H. S., Shields, A., Yanov, S., Yanova, G., Fitzmaurice, G. M., Nelson, A. K., Greenfield, S. F., & Tomsk Tuberculosis Alcohol Working Group (2013) · Addiction · doi:10.1111/add.12148 · Cited by 44
Wilkinson, D. G., & Davies, G. (1997) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.1997.d01-358.x · Cited by 44
Determinants of mortality in elderly patients with tuberculosis: a population-based follow-up study
Yen, Y., Feng, J., Pan, S., Chuang, P., Su, V. Y., & SU, W.-J. (2017) · Epidemiology and Infection · doi:10.1017/s0950268817000152 · Cited by 44
van den Boogaard, J., Lyimo, R. A., Irongo, C. F., Boeree, M. J., Schaalma, H. P., Aarnoutse, R. E., & Kibiki, G. S. (2009) · PubMed · Cited by 42
MacIntyre, C. R., Goebel, K., Brown, G. V., Skull, S., Starr, M., & FULLINFAW, R. O. (2003) · PubMed · Cited by 40
Akkslip, S., Rasmithat, S., Maher, D., & Sawert, H. (1999) · PubMed · Cited by 39
Zvavamwe, Z., & Ehlers, V. J. (2008) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2008.09.013 · Cited by 38
Miti, S., Mfungwe, V., Reijer, P., & Maher, D. (2003) · PubMed · Cited by 35
Community DOT for tuberculosis in a Brazilian favela: comparison with a clinic model.
Cavalcante, S. C., Soares, E., Pacheco, A. G., Chaisson, R. E., & Durovni, B. (2007) · PubMed · Cited by 35
Food incentives improve adherence to tuberculosis drug treatment among homeless patients in Russia
Gärdén, B., Samarina, A., Stavchanskaya, I., Alsterlund, R., Övregaard, A., Taganova, O., Shpakovskaya, L., Жемков, В. Ф., Ridell, M., & Larsson, L.-O. (2012) · Scandinavian Journal of Caring Sciences · doi:10.1111/j.1471-6712.2012.01009.x · Cited by 35
Treatment default and death among tuberculosis patients in Hunan, China
Abuaku, B. K., Tan, H., Li, X., Chen, M., & Huang, X. (2010) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365540903493723 · Cited by 35
Chien, J., Lai, C., Tan, C., Chien, S.-T., Yu, C., & Hsueh, P. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt103 · Cited by 35 · cited 1×
“Only three CSs compared the impact of DOT on the development of drug resistance compared with SAT, one of which found no significant difference [4,59,70].”
BackgroundOkanurak, K., Kitayaporn, D., Wanarangsikul, W., & Koompong, C. (2007) · PubMed · Cited by 34
Ong’ang’o, J. R., Mwachari, C., Kipruto, H., & Karanja, S. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088937 · Cited by 34
Filho, J. P. C. (2009) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132009001000008 · Cited by 34
Davidson, B. L. (1998) · CHEST Journal · doi:10.1378/chest.114.5.1239 · Cited by 33
Pungrassami, P., Johnsen, S. P., Chongsuvivatwong, V., & Olsen, J. (2002) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2002.00849.x · Cited by 33
Juan, G., Lloret, T., Perez, C., López, P. G., Navarro, R., Ramón, M. M. V., Cortijo, J., & Morcillo, E. J. (2006) · PubMed · Cited by 33
Managing medication compliance of tuberculosis patients in Haiti with medication monitors.
Moulding, T., & Caymittes, M. (2002) · PubMed · Cited by 31
Tuberculosis treatment outcome monitoring: Blackburn 1988-2000.
Lp, O., Horsfield, N., & Rm, G. (2002) · PubMed · Cited by 31
Does routine home visiting improve the return rate and outcome of DOTS patients who delay treatment?
MOHAN, A. K., Nassir, H. A. Z., & Niazi, A. (2003) · Eastern Mediterranean Health Journal · doi:10.26719/2003.9.4.702 · Cited by 29
Hsieh, C., Lin, L., Kuo, B. I., Chiang, C., Su, W., & Shih, J.-F. (2007) · Journal of Clinical Nursing · doi:10.1111/j.1365-2702.2006.01924.x · Cited by 28
Ershova, J. V., Podewils, L. J., Murrison, L. B., Stockwell, H. G., Dlamini, S. S., & Mametja, L. D. (2014) · South African Medical Journal · doi:10.7196/samj.7655 · Cited by 27
Ritchie, L. M. P., Schull, M. J., Martiniuk, A. L. C., Barnsley, J. M., Arenovich, T., van Lettow, M., Chan, A. K., Mills, E. J., Makwakwa, A., & Zwarenstein, M. (2015) · Implementation Science · doi:10.1186/s13012-015-0228-y · Cited by 26
Chua, A. P.-G., Lim, L., Ng, H., Chee, C., & Wang, Y.-T. (2015) · Singapore Medical Journal · doi:10.11622/smedj.2015054 · Cited by 26
Alvarez‐Uria, G., Pakam, R., Midde, M., & Naik, P. K. (2014) · Journal of the International AIDS Society · doi:10.7448/ias.17.1.19251 · Cited by 26
Dave, P., Shah, A. N., Nimavat, P. B., Modi, B., Pujara, K. R., Patel, P., Mehariya, K., Rade, K., Shekar, S., Sachdeva, K. S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148488 · Cited by 25
Kapella, B. K., Anuwatnonthakate, A., Komsakorn, S., Moolphate, S., Charusuntonsri, P., Limsomboon, P., Wattanaamornkiat, W., Nateniyom, S., & Varma, J. K. (2009) · PubMed · Cited by 24
Chan, P., Huang, S.-H., Yu, M.-C., Lee, S.-W., Huang, Y.-W., Chien, S.-T., Lee, J., & and the, T. M. T. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057719 · Cited by 23
Ollé-Goig, J. E., & Álvarez, J. J. S. (2001) · PubMed · Cited by 23
Snyder, R. E., Marlow, M. A., Phuphanich, M. E., Riley, L. W., & Maciel, E. L. N. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1835-1 · Cited by 23
Snidal, S. J., Barnard, G., Atuhairwe, E., & Amor, Y. B. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0413 · Cited by 22
Involving community partners in the management of tuberculosis among drug users
Duarte, R., Santos, A., Mota, M., Carvalho, A., Marqués, J., & Barros, H. (2011) · Public Health · doi:10.1016/j.puhe.2010.09.002 · Cited by 22
Mathema, B., Pande, S. B., Jochem, K., Houston, R. A., Smith, I., Bam, D. S., & McGowan, J. E. (2001) · PubMed · Cited by 22
Singh, A., Parasher, D., Shekhavat, G. S., Sahu, S. K., Wares, D. F., & Granich, R. (2004) · PubMed · Cited by 21
Effects of pay-for-performance system on tuberculosis default cases control and treatment in Taiwan
Tsai, W., Kung, P., Khan, M. M., Campbell, C. R., Yang, W.-T., Lee, T.-F., & Li, Y.-H. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.06.016 · Cited by 21
Mhimbira, F., Hella, J., Maroa, T., Kisandu, S., Chiryamkubi, M., Said, K., Mhalu, G., Mkopi, A., Mutayoba, B. K., Reither, K., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161171 · Cited by 21
Atkins, S. A., Lewin, S. R., Jordaan, E., & Thorson, A. E. (2011) · PubMed · Cited by 20
Vieira, A. A., & Ribeiro, S. A. (2011) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132011000200013 · Cited by 20
Impact of community tracer teams on treatment outcomes among tuberculosis patients in South Africa
Murrison, L. B., Podewils, L. J., Peters, A. C., Somnath, P., Nshuti, L., der Walt, M. L. V., & Mametja, L. D. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-621 · Cited by 20 · cited 4×
“(B) Sensitivity analysis: removing the heaviest weighted study (Bronner 2012) in which control and intervention cohorts had significantly different pre-intervention loss to follow-up rates.”
BackgroundInfluentialEstrategia educativa para incrementar el cumplimiento del régimen antituberculoso en Chiapas, México
Gordillo, G. D. C. Á., Gordillo, J. F. Á., & Jiménez, J. E. D. (2003) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892003001100005 · Cited by 20
Soares, E., Vollmer, W. M., Cavalcante, S. C., Pacheco, A. G., Saraceni, V., Silva, J. S., Neves, G., Golub, J. E., Efron, A. R., Durovni, B., et al. (2013) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.13.0152 · Cited by 20
Becx-Bleumink, M., Wibowo, H. A., Apriani, W., & Vrakking, H. (2001) · PubMed · Cited by 20
Das, M., Isaakidis, P., Armstrong, E. A., Gundipudi, N. R., Babu, R. B., Qureshi, I. A., Claes, A., Mudimanchi, A. K., Prasad, N., Mansoor, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092131 · Cited by 18
Household members and health care workers as supervisors of tuberculosis treatment
Maciel, E. L. N., Guidoni, L. M., Brioshi, A. P., do Prado, T. N., Fregona, G. C., Hadad, D. J., Molino, L. P., Palaci, M., Johnson, J. L., & Dietze, R. (2010) · Revista de Saúde Pública · doi:10.1590/s0034-89102010000200015 · Cited by 18
Radilla-Chávez, P., & Laniado-Laborı́n, R. (2007) · PubMed · Cited by 18
Cohort analysis of directly observed treatment outcomes for tuberculosis patients in urban Pakistan.
Akhtar, S., Rozi, S., White, F., & Hasan, R. (2011) · PubMed · Cited by 16
Success of community-based directly observed anti-tuberculosis treatment in Mongolia
Dobler, C. C., Körver, S., Batbayar, O., Oyuntsetseg, S., Tsolmon, B., Wright, C. M., Солонго, Б., & Marais, B. J. (2015) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.14.0927 · Cited by 16
Banerjee, A., Harries, A. D., Mphasa, N., Nyirenda, T. E., Veen, J., Ringdal, T., van Gorkom, J., & Salaniponi, F. M. L. (2000) · PubMed · Cited by 15
Krishnaswami, K. V., Somasundaram, P. R., Tripathy, S. P., Vaidyanathan, B., Radhakrishna, S., & Fox, W. (1981) · Tubercle · doi:10.1016/0041-3879(81)90017-9 · Cited by 15
Zou, G., Wei, X., Witter, S., Yin, J., Walley, J. D., Liu, S., Yang, H., Chen, J., Tian, G., & Mei, J. (2013) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0799 · Cited by 14
Mohr-Holland, E., Daniels, J., Beko, B., Isaakidis, P., Cox, V., Steele, S. J., Muller, O., Snyman, L., Azevedo, V. D., Shroufi, A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178054 · Cited by 14 · cited 2×
“Six CSs included primarily HIV/TB patients [51,53–55,57,72] and two CSs involved primarily MDR-TB patients [56,72].”
BackgroundImpact of community participation on treatment outcomes and compliance of DOTS patients in Iraq
Niazi, A. D., & Delaimi, A. M. A. (2003) · Eastern Mediterranean Health Journal · doi:10.26719/2003.9.4.709 · Cited by 14
Factors influencing the successful treatment of infectious pulmonary tuberculosis.
Chung, W., Chang, Y. C., & Yang, M. (2007) · PubMed · Cited by 13
Thai health education program for improving TB migrant's compliance.
Khortwong, P., & Kaewkungwal, J. (2013) · PubMed · Cited by 13
Yen, Y., Yen, M.-Y., Lin, Y.-P., Shih, H.-C., Li, L.-H., Chou, P., & Deng, C.-Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079644 · Cited by 13
Lu, H. J., Yan, F., Wang, W., Wu, L., Wei-ping, M., Chen, J., Shen, X., & Mei, J. (2013) · Western Pacific surveillance response journal · doi:10.5365/wpsar.2013.4.1.003 · Cited by 13
Tuberculosis treatment delivery in high burden settings: does patient choice of supervision matter?
Kironde, S., & Meintjies, M. (2002) · PubMed · Cited by 13
Mac, J. T., Doordan, A., & Carr, C. A. (1999) · Public Health Nursing · doi:10.1046/j.1525-1446.1999.00426.x · Cited by 11 · cited 1×
“With regard to relapse rates, one RCT [158] and four CSs [40,54,59,67] found no significant differences between DOT and SAT, while two CSs saw a decline in relapse rates with DOT [4,38].”
ResultTandon, M., Gupta, M., Tandon, S., & Gupta, K. B. (2002) · PubMed · Cited by 9
Ngamvithayapong-Yanai, J., Luangjina, S., Nedsuwan, S., Kantipong, P., Wongyai, J., & Ishikawa, N. (2013) · Western Pacific surveillance response journal · doi:10.5365/wpsar.2012.3.4.013 · Cited by 9
Nirupa, C., Sudha, G., Santha, T., Ponnuraja, C., Fathima, R., Chandrasekaran, Jaggarajamma, K., Thomas, A., Gopi, P. G., & Parameswaran, N. (2005) · NIRT Institutional Scholarship Repository (National Institute of Research in Tuberculosis) · Cited by 8
Safdar, N., Hinderaker, S. G., Baloch, N. A., Enarson, D. A., Khan, M. A., & Mørkve, O. (2011) · BMC Health Services Research · doi:10.1186/1472-6963-11-187 · Cited by 7
Abassi, A., & Mansourian, A. R. (2007) · PubMed · Cited by 7
Tripathy, S. K., Kumar, P. P., Sagili, K. D., & Enarson, D. A. (2013) · Public Health Action · doi:10.5588/pha.13.0043 · Cited by 6
Outcome of directly observed therapy for tuberculosis in Yokohama City, Japan.
Tsuchida, K., & Koyanagi, H. (2003) · PubMed · Cited by 6
Wai, P. P., Shewade, H. D., Kyaw, N. T. T., Kyaw, K. W. Y., Thein, S., Thu, A. S., Oo, M. M., Htwe, P. S., Tun, M. M. T., Maung, H. M. W., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187223 · Cited by 6
[Community involvement in tuberculosis care in three rural health districts of Burkina Faso].
Drabo, M., Zerbo, R., Berthé, A., Ouedrago, L., Konfe, S., Mugisho, E., Dujardin, B., & Macq, J. (2009) · PubMed · doi:10.3917/spub.095.0485 · Cited by 5
Daniel, O. J. (2006) · Tropical Doctor · doi:10.1258/004947506777978280 · Cited by 3
Treatment Outcomes in Culture-Positive Pulmonary Tuberculosis
Siemion-Szcześniak, I., & Kuś, J. (2008) · Advances in respiratory medicine · doi:10.5603/arm.27848 · Cited by 3
Kingkaew, N., กิ่งแก้ว, น., Sangtong, B., สังข์ทอง, บ., Amnuaiphon, W., อํานวยผล, ว., Jongpaibulpatana, J., จงไพบูลย์พัฒนะ, เ., Anuwatnonthakate, A., & อนุวัฒน์นนทเขตต์, อ. (2008) · Cited by 1
Research works printed but not linked: 7
- Alipanah N, Jarlsberg L, Miller C, Lechner A, Wai K, Nahid P. Report for Systematic Review for Adherence Interventions in TB Treatment. World Health Organization guidelines for treatment of drug-susceptible tuberculosis and patient care. 2017;Annex 5.
- 2014, Review Manager (RevMan)
- T Chennai, 1997, A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis, Tuberculosis Research Centre. Int J Tuberc Lung Dis, 1, 509
- AA Vieira, 2011, Compliance with tuberculosis treatment after the implementation of the directly observed treatment, short-course strategy in the city of Carapicuiba, Brazil, J Bras Pneumol, 37, 223
- VK Arora, 2003, Community mediated domiciliary DOTS execution—A study from New Delhi, Ind J Tub, 50, 143
- JP Cantalice Filho, 2009, Food baskets given to tuberculosis patients at a primary health care clinic in the city of Duque de Caxias, Brazil: effect on treatment outcomes, J Bras Pneumol, 35, 992
- RP Paramasivan, 1993, Short course chemotherapy: A controlled study of indirect default retrieval method, Ind J Tub, 40, 185
Cited by
Chakaya, J., Khan, M., Ntoumi, F., Aklillu, E., Fatima, R., Mwaba, P., Kapata, N., Mfinanga, S., Hasnain, S. E., Katoto, P. D. M. C., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.02.107 · Cited by 1,104
“An approach that is based on providing omprehensive and individualized support to people being treated or TB is more likely to be acceptable to people with TB and their amilies and has been associated with better treatment completion ates (Alipanah et al., 2018).”
BackgroundTreatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
Nahid, P., Mase, S. R., Migliori, G. B., Sotgiu, G., Bothamley, G. H., Brozek, J. L., Cattamanchi, A., Cegielski, J. P., Chen, L., Daley, C. L., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201909-1874st · Cited by 462
“compared with health facility–based DOT or self-administered therapy (11, 39).”
MethodSelf-citationDheda, K., Perumal, T., Moultrie, H., Perumal, R., Esmail, A., Scott, A. J., Udwadia, Z., Chang, K. C., Peter, J., Pooran, A., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00092-3 · Cited by 292
“140 Lessons learned in design, technological application, testing and fast-tracking of clinical trials, funding, development, and distribution of the SARS-CoV-2 vaccines could also be applied to accelerate tuberculosis vaccine development.”
BackgroundStrategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries
Godman, B., Egwuenu, A., Haque, M., Malande, O. O., Schellack, N., Kumar, S., Saleem, Z., Sneddon, J., Hoxha, I., Islam, S., et al. (2021) · Life · doi:10.3390/life11060528 · Cited by 237
Subbaraman, R., Nathavitharana, R. R., Mayer, K. H., Satyanarayana, S., Chadha, V. K., Arinaminpathy, N., & Pai, M. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002754 · Cited by 211
Metadata
- Authors
- Alipanah, N., Jarlsberg, L., Miller, C., Linh, N. N., Falzon, D., Jaramillo, E., & Nahid, P.
- Affiliations
- University of California, San Francisco (US)
- World Health Organization (CH)
- Corresponding author
- Nahid, Payam
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-07-03
- Volume
- 15
- Issue
- 7
- Pages
- e1002595
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC6029765
- OpenAlex
- W2810683857
- Cited by
- 503
- References
- 156
- Citations by year
- 2026: 48 · 2025: 75 · 2024: 79 · 2023: 88 · 2022: 75 · 2021: 67 · 2020: 42 · 2019: 26 · 2018: 3
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (publishedVersion)
- eScholarship (California Digital Library) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Funders
- World Health Organization
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Keywords
- tuberculosis, medication adherence, directly observed therapy, drug-resistant tuberculosis, self-administered therapy, sputum smear conversion, treatment failure, drug resistance development, incentives, patient education, video-observed therapy, mobile phone reminders, treatment success, relapse, transmission risk, multidrug therapy, patient-provider relationship
- MeSH terms
- Adolescent, Adult, Antitubercular Agents, Attitude of Health Personnel, Child, Child, Preschool, Health Personnel, Humans, Infant, Infant, Newborn, Health Knowledge, Attitudes, Practice, Patient Education as Topic, Risk Factors, Self Care, Tuberculosis, Video Recording, Randomized Controlled Trials as Topic, Treatment Outcome, Telemedicine, Directly Observed Therapy, Cell Phone, Medication Adherence, Text Messaging, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.